Speaker illustration

Ms Angela Tomasovic

Institute of Pharmacology and Toxicology, Wuerzburg (Germany)

The dimer interface of ERK1/2 provides a potential strategy for selective inhibition of pathological cardiac hypertrophy

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Cell Signalling

Session: Young Investigator Award: Basic Science and Translational Science


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb